- Novel Microdevices Establishes GMP Development Base at LaunchPort
Company is developing manufacturing processes to pursue innovative diagnostic products for sexually transmitted infections and respiratory diseases.
- Medical device accelerator LaunchPort adds tenants, mulls expansion in Port Covington
Baltimore Business Journal article overviews LaunchPort’s most recent news. Editor’s Choice Article.
- Eyedea Medical Joins Baltimore’s LaunchPort™ Medtech Venture Center
Company alleviates the global burden of corneal blindness through innovative solutions in eye banking and corneal transplantation
- The LaunchPort virtual resident Brevitest moves closer to launch of COVID-19 Antibody test
BreviTest Technologies announced that the FDA has officially accepted BreviTest’s notification of its intent to commercially distribute its IgG antibody test. The BreviTest SARS-CoV-2 IgG Test detects the presence of SARS-CoV-2 specific IgG antibodies in plasma or serum using only 3μl of sample. Reliable results are available in 10 minutes. A positive test result indicates prior exposure to the virus and potential immunity.
- CoapTech Closes $7M Series B Investment
CoapTech announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.
News Article: https://hunniwell.com/coaptech-series-b/
- LaunchPort Recognized by Baltimore Business Journal for Best in Tech 2020
Congratulations to all of the companies being recognized as winners of this year’s Best in Tech Awards for your work to advance Baltimore’s tech industry. The honorees, who were chosen by BBJ staff, represent the incredible, growing tech ecosystem here in Baltimore, one fueled by world-class assets, phenomenal talent and a commitment to excellence. Baltimore has created a culture that celebrates innovation and business creation — a welcoming hub for those with the grit, determination and resources to successfully scale our tech enterprises.
- How Port Covington Is Contributing To The Global Effort To Save Lives
The Port Covington team at Weller Development outlines how a broad array of commercial and social interests are contributing to efforts against the COVID-19 outbreak. The LaunchPort is prominently featured across a range of activities.
News Article: https://pc.city/port-covington-pandemic-efforts/?utm_source=Port+Covington&utm_campaign=281a5a864c-EMAIL_CAMPAIGN_2020_05_07_01_43&utm_medium=email&utm_term=0_f7827aefa7-281a5a864c-82212381
- Brevitest Technologies Becomes First Remote Resident of Baltimore’s LaunchPort™ Manufacturing Accelerator
The LaunchPort™ announced today that Brevitest Technologies will become the latest out-of-state company to partner with the device accelerator. Brevitest has developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent assays (ELISAs), the gold standard for measuring concentrations of molecules in solution. Unlike ELISAs done in laboratories, the technology is portable with a run time of less than 15 minutes. Developed as a platform technology, capable of performing a wide variety of tests with laboratory-quality sensitivity and specificity, the assays are targeted at numerous clinical, forensic, environmental and lifestyle applications. The newest version of the device is currently undergoing review to allow rapid point-of-care COVID-19 testing. The unique nature of the relationship – which involves both LaunchPort and Engineering Medical Systems – gives Brevitest immediate access to design control and manufacturing protocols that will allow their internal development team to convert the functional prototypes to a marketable product in a little over a month. Simultaneously, those reviews are preparing the product for the eventual broader launch into opioid testing and other infectious diseases.
- Key Tech Inc. Assembles Positive Pressure Air Respirators at LaunchPort
Baltimore engineering design firm Key Tech Inc. sets up positive pressure air respiratory assembly operation at The LaunchPort in response to requests from area hospitals. The positive pressure suits were on back order through the end of the summer, and Key Tech and Johns Hopkins collaborated to design and assemble the blower assemblies from readily available components to back fill the demand.
- LifeSprout closes $28.5M Series A round
Company closed round that was led by investors from San Francisco and Baltimore, allowing the Johns Hopkins spin-out to continue clinical development of its first product. LifeSprout is a LaunchPort Resident that operates clean room, wet lab and engineering cells as part of their GMP process development efforts.
- Paul Dryden FDA Medical Devices Seminar kicked off LaunchPort regulatory programming
On February 11, 2020, Paul Dryden of ProMedic, LLC turned out a large crowd to speak about the process for planning and executing regulatory submissions in the medical device sector. The group welcomed Dorn Carranza, FDA/CDRH’s new Director of Innovation to his first visit to Baltimore and Port Covington.
Look for Paul’s presentation in the Resources section at the bottom of this page.
- ExoRenal joins The LaunchPort™ Medical Device Accelerator
Company aims to develop next generation home dialysis technology.
- Hunt Valley-based Longeviti Neuro Solutions is adding a presence in Port Covington’s medical manufacturing space
Company’s expanded sterilization capacity is first step in projected product line growth for Baltimore for neuro-implant company.
- Engineered Medical Systems and The LaunchPort™ Partner with Longeviti Neuro Solutions
Hydrogen Peroxide sterilization capacity added to expand Longeviti product lines, and to allow regional device researcher access to latest development capabilities.
- Year in Review 2019: Biggest tech moves, expansions in Maryland
LaunchPort among the tech highlights of 2019
- San Francisco medical device firm moving manufacturing to Baltimore
Well-funded medical device company eNeura Inc. is moving its manufacturing and customer service operations from California to Baltimore to be near its corporate offices and local funders.
- LifeSprout’s Growth Leads Company to New Manufacturing Space in Baltimore
The Johns Hopkins startup, which is developing next-generation synthetic soft tissues for reconstructive and aesthetic surgical procedures, relocates to LaunchPort as they expand
- LaunchPort medical device accelerator expanding in City Garage
LaunchPort increased space at City Garage by about 50% to accommodate increasing demand by Resident companies.
News Article Link: LaunchPort medical device accelerator expanding in City Garage
- Maryland and Israel launch MarketReach America program
LaunchPort’s Managing Director to lead Lean Start-up Discovery program for the Maryland Israel Development Center. The program is a partnership between MIDC, the Israel Innovation Authority, Abell Foundation, University of Maryland and the Maryland Department of Commerce.
- Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington
Vixiar Medical recently closed a $1.5 million financing round and is preparing for regulatory submissions and commercial launch. Local investors included TEDCO and the Abell Foundation.
News Article: http://www.prweb.com/releases/2017/09/prweb14720477.htm
- Novel Medical Device Manufacturing Operation and Accelerator Coming to Port Covington
The MVR Company and Engineered Medical Systems announce their new Medical Device venture in Port Covington, Baltimore, Maryland
News Article: http://www.prweb.com/releases/2017/08/prweb14636787.htm